EGFR and sarcoma: Notably, most of such transformation were induced by drug treatment that led to acquired resistance, including squamous transformation of EGFR-positive LUADs27–35, transformation of ASCs into LUSCs, small cell lung cancers, or sarcomas (through epithelial–mesenchymal transition) and from LUADs into ASCs27,36–38.